QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx RiseZacks Investment Research • 09/03/25
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic TestingBusiness Wire • 09/02/25
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible BondsBusiness Wire • 08/28/25
QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible BondsBusiness Wire • 08/28/25
Why Qiagen (QGEN) International Revenue Trends Deserve Your AttentionZacks Investment Research • 08/11/25
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitabilityBusiness Wire • 08/05/25
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory BoardBusiness Wire • 06/26/25
QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its StockZacks Investment Research • 06/19/25
QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development PartnershipBusiness Wire • 06/18/25
QGEN Stock Rises in After Market Following Partnership With IncyteZacks Investment Research • 06/16/25
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)Business Wire • 06/15/25